Human RECQ1 promotes restart of replication forks reversed by DNA topoisomerase I inhibition

Matteo Berti, Arnab Ray Chaudhuri, Saravanabhavan Thangavel, Shivasankari Gomathinayagam, Sasa Kenig, Marko Vujanovic, Federico Odreman, Timo Glatter, Simona Graziano, Ramiro Mendoza-Maldonado, Francesca Marino, Bojana Lucic, Valentina Biasin, Matthias Gstaiger, Ruedi Aebersold, Julia M. Sidorova, Raymond J. Monnat, Massimo Lopes, Alessandro Vindigni

Research output: Contribution to journalArticlepeer-review

321 Scopus citations


Topoisomerase I (TOP1) inhibitors are an important class of anticancer drugs. The cytotoxicity of TOP1 inhibitors can be modulated by replication fork reversal through a process that requires poly(ADP-ribose) polymerase (PARP) activity. Whether regressed forks can efficiently restart and what factors are required to restart fork progression after fork reversal are still unknown. We have combined biochemical and EM approaches with single-molecule DNA fiber analysis to identify a key role for human RECQ1 helicase in replication fork restart after TOP1 inhibition that is not shared by other human RecQ proteins. We show that the poly(ADP-ribosyl)ation activity of PARP1 stabilizes forks in the regressed state by limiting their restart by RECQ1. These studies provide new mechanistic insights into the roles of RECQ1 and PARP in DNA replication and offer molecular perspectives to potentiate chemotherapeutic regimens based on TOP1 inhibition.

Original languageEnglish
Pages (from-to)347-354
Number of pages8
JournalNature Structural and Molecular Biology
Issue number3
StatePublished - Mar 2013


Dive into the research topics of 'Human RECQ1 promotes restart of replication forks reversed by DNA topoisomerase I inhibition'. Together they form a unique fingerprint.

Cite this